CIFAR receives $4M to strengthen health research in B.C.
CIFAR (The Canadian Institute for Advanced Research) welcomes the announcement by British Columbia’s Ministry of Health that it has made a contribution of $4 million to the Institute.
“We thank the Ministry of Health for its support for CIFAR and our mission to enable research that changes the world by forming collaborative networks of some of the top researchers in British Columbia and around the globe,” said Dr. Alan Bernstein, CIFAR president and CEO. “Starting right from CIFAR’s beginnings, the province of British Columbia has been one of our most important partners.”
This funding builds on previous investments in CIFAR. Since 2003, B.C.’s government has provided $20.6 million to CIFAR.
“Through partnerships with organizations like CIFAR, we’re working on providing researchers in B.C. with supports they need to answer the biggest health questions facing British Columbians, from cancer to asthma,” said Health Minister Terry Lake. “This plays a major role in shaping the province’s economy and competitiveness – aspects that are integral in supporting our strong BCTECH Strategy.”
CIFAR supports more than 60 researchers in B.C. across a range of research areas including: determining how drugs might be designed to destroy cancer cells without affecting healthy cells, child health and development, and genomics. These projects include research by award-winning microbiologist Dr. Brett Finlay, Co-Director of CIFAR’s new Humans & the Microbiome program.
Dr. Finlay’s lab at the University of British Columbia explores the important role that microbes (including bacteria and viruses) play in human health. He studies microbes, like E. coli and salmonella, that can make people sick as well as the many microbes critical to keeping humans healthy. Recently, he began examining the connection between early childhood antibiotic use and asthma, and found four specific healthy bacteria that, if present in the first three months of life, reduce the risk of developing asthma.
“CIFAR’s role is extremely important. With their support, we are allowed the time to explore a problem and discuss it with top researchers from around the world,” said Dr. Finlay.
Associate Director, Public Policy
CIFAR congratulates Vector Institute, governments of Canada and Ontario on artificial intelligence investments
CIFAR President & CEO Dr. Alan Bernstein congratulated the Vector Institute and the governments of Canada and Ontario for the...
“We talk misconceptions about quantum physics, the importance of global research collaboration and Nobel prize aspirations with the award-winning Canadian...
CIFAR President & CEO Dr. Alan Bernstein has been awarded the 2017 Henry G. Friesen International Prize in Health Research...
In Budget 2017 the Government of Canada announced it will renew and enhance its funding for CIFAR, investing $35 million...